IRRITABLE-BOWEL-SYNDROME  RACEMIC PROTEIN CRYSTALLOGRAPHY  X-RAY STRUCTURES  GASTROINTESTINAL-TRACT  PREVALENCE  LIGATION  PATTERNS  IMPACT  Linaclotide  Guanylyl cyclase  Protein chemical synthesis  Fmoc solid phase peptide synthesis  Racemic crystallization  

FXS  hippocampus  long-term plasticity  spatial learning  intellectual disability  FRAGILE-X-SYNDROME  SPONTANEOUSLY HYPERTENSIVE-RAT  MENTAL-RETARDATION PROTEIN  KNOCKOUT MICE  MOUSE MODEL  SYNAPTIC PLASTICITY  SOCIAL-BEHAVIOR  POTENTIATION  GENE  EXPRESSION  

Acupuncture modulation  Acupuncture modulation of pain  Amygdala  Axonal reflex  Behavioral pain hypersensitivity  Bell-magendie law  Biochemical neuroimaging  Brain matrix  Brain mechanisms  Cerebellum  Cortical and subcortical processing  Disinhibition  Drug modulation  Functional neuroimaging  Gabapentin  Gatecontrol theory of pain  Gene therapy and stem cell treatment  Glial cells  Hyperalgesia  Hypothalamus  Insula  K2P  Nerve injury-induced neural plasticity  Neurochemical markers  Neurogenic inflammation  Neuromodulation  Neuromodulation  Neuropathic  Nociception  Nociceptive flexion reflex (NFR)  Nociceptive specific (NS) neurons  Nonsteroidal anti-inflammatory drugs (NSAIDs)  P2X3 receptor  P2Y receptors  Pain  Pain  Pain  Pain  Pain  Pain  Pain matrix  Peptidergic population of c nociceptors  Periaqueductal gray (PAG)  Peripheral mechanisms  Peripheral nociceptors  Placebo modulation  Placebo modulation  Primary afferent depolarization (PAD)  Pro-inflammatory cytokines  Psychological modulation  Rostral ventromedial medulla (RVM)  Specificity theory  Spinal cord dorsal horn  Spinal pain sensory neurons  Structural neuroimaging  Tanezumab  Thalamic pain syndrome  Transient receptor potential vanilloid receptor 1 (TRPV1)  Tripartite synaptic model  Vanilloid receptor-like protein 1 (VRL1)  Ventrolateral orbital cortex (VLO)  Voltage-gated potassium channels (VGPCs)  Voxel-based morphometry  Windup phenomenon  

fragile X related protein 1  CMP-N-acetylneuraminic acid synthetase  fragile X syndrome  GM1  

apo  apolipoprotein  HDL  high-density lipoprotein  HNF-1α,4α  hepatocyte nuclear factor-1α,4α  LRH-1  liver receptor homolog-1  Foxa2  forkhead box A2  PAF  platelet activating factor  LXR  liver X receptor  RXR  retinoid X receptor  FXR  farnesoid X receptor  SHP  small heterodimer partner  S1P  Sphingosine-1-Phosphate  CVD  cardiovascular disease  HDL-C  HDL cholesterol  RCT  reverse cholesterol transport  MHC  major histocompatibility complex class III  TNF  tumor necrosis factor  HRP  haptoglobin-related protein  PON-I  paraoxonase-1  SNP  single nucleotide polymorphism  T1,2D  type 1,2 diabetes  RA  rheumatoid arthritis  ABCA1  ATP-binding cassette transporter A1  PPAR-γ  peroxisome proliferator-activated receptor γ  IL  interleukin  ABCG  ATP-binding cassette sub-family G  CETP  cholesteryl ester transfer protein  SR-B1  scavenger receptor class B member 1  MODY3  maturity-onset diabetes of the young type 3  MUP  major urinary protein  RBP  retinol binding protein  RAR  retinoic acid receptor  TR  thyroid hormone receptor  PI3K  phosphatidylinositol 3-kinase  DHC  dihydrocapsaicin  HRE  hormone response element  IGF-1  insulin-like growth factors  PAF-R  platelet activating factor receptor  TGF-α,β  transforming growth factor-α,β  EGF  epidermal growth factor  HGF  hepatic growth factor  VLDL  very low-density lipoprotein  LDL  low-density lipoprotein  ldlr  LDL receptor  ldlr−/−  LDL-receptor deficient  LCAT  lecithin-cholesterol acyltransferase  CE  cholesteryl ester  TC  total cholesterol  LDL-C  LDL cholesterol  VLDL-C  VLDL cholesterol  CHD  coronary heart disease  Mets  metabolic syndrome  S1PR  S1P receptor  NF-κB  nuclear factor-κB  NO  nitrogen oxide  eNOS  endothelial nitric oxide synthase  apoM-TgN mice  mice overexpressing human apoM by approximately two-fold  apoM-TgH mice  mice overexpressing human apoM by approximately ten-fold  apoM−/− mice  apoM-null mice  apoE−/−  apoE-null mice  Apolipoprotein M  Regulation  Function